Cargando…
Comparing psychotropic medication prescribing in personality disorder between general mental health and psychological services: retrospective cohort study
BACKGROUND: Although no drugs are licensed for the treatment of personality disorder, pharmacological treatment in clinical practice remains common. AIMS: This study aimed to estimate the prevalence of psychotropic drug use and associations with psychological service use among people with personalit...
Autores principales: | Kadra-Scalzo, Giouliana, Garland, Jacqueline, Miller, Stephen, Chang, Chin-Kuo, Fok, Marcella, Hayes, Richard D., Moran, Paul, Shetty, Hitesh, Young, Allan H., Stewart, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058890/ https://www.ncbi.nlm.nih.gov/pubmed/33762065 http://dx.doi.org/10.1192/bjo.2021.34 |
Ejemplares similares
-
Antipsychotic polypharmacy prescribing and risk of hospital readmission
por: Kadra, Giouliana, et al.
Publicado: (2017) -
Predicting parkinsonism side-effects of antipsychotic polypharmacy prescribed in secondary mental healthcare
por: Kadra, Giouliana, et al.
Publicado: (2018) -
Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine
por: Kesserwani, Jad, et al.
Publicado: (2019) -
Defining severity of personality disorder using electronic health records: short report
por: Monk-Cunliffe, Jonathan, et al.
Publicado: (2023) -
Predictors of long-term (≥ 6 months) antipsychotic polypharmacy prescribing in secondary mental healthcare
por: Kadra, Giouliana, et al.
Publicado: (2016)